Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.

Rosmarin D, Palles C, Church D, Domingo E, Jones A, Johnstone E, Wang H, Love S, Julier P, Scudder C, Nicholson G, Gonzalez-Neira A, Martin M, Sargent D, Green E, McLeod H, Zanger UM, Schwab M, Braun M, Seymour M, Thompson L, Lacas B, Boige V, Ribelles N, Afzal S, Enghusen H, Jensen SA, Etienne-Grimaldi MC, Milano G, Wadelius M, Glimelius B, Garmo H, Gusella M, Lecomte T, Laurent-Puig P, Martinez-Balibrea E, Sharma R, Garcia-Foncillas J, Kleibl Z, Morel A, Pignon JP, Midgley R, Kerr D, Tomlinson I

Open source

DOI
10.1200/jco.2013.51.1857
Published
2014 Apr 1
Container
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jco.2013.51.1857,
  title = {Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.},
  author = {Rosmarin D and Palles C and Church D and Domingo E and Jones A and Johnstone E and Wang H and Love S and Julier P and Scudder C and Nicholson G and Gonzalez-Neira A and Martin M and Sargent D and Green E and McLeod H and Zanger UM and Schwab M and Braun M and Seymour M and Thompson L and Lacas B and Boige V and Ribelles N and Afzal S and Enghusen H and Jensen SA and Etienne-Grimaldi MC and Milano G and Wadelius M and Glimelius B and Garmo H and Gusella M and Lecomte T and Laurent-Puig P and Martinez-Balibrea E and Sharma R and Garcia-Foncillas J and Kleibl Z and Morel A and Pignon JP and Midgley R and Kerr D and Tomlinson I},
  year = {2014},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco.2013.51.1857},
  url = {https://doi.org/10.1200/jco.2013.51.1857}
}

RIS

TY  - JOUR
TI  - Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.
AU  - Rosmarin D
AU  - Palles C
AU  - Church D
AU  - Domingo E
AU  - Jones A
AU  - Johnstone E
AU  - Wang H
AU  - Love S
AU  - Julier P
AU  - Scudder C
AU  - Nicholson G
AU  - Gonzalez-Neira A
AU  - Martin M
AU  - Sargent D
AU  - Green E
AU  - McLeod H
AU  - Zanger UM
AU  - Schwab M
AU  - Braun M
AU  - Seymour M
AU  - Thompson L
AU  - Lacas B
AU  - Boige V
AU  - Ribelles N
AU  - Afzal S
AU  - Enghusen H
AU  - Jensen SA
AU  - Etienne-Grimaldi MC
AU  - Milano G
AU  - Wadelius M
AU  - Glimelius B
AU  - Garmo H
AU  - Gusella M
AU  - Lecomte T
AU  - Laurent-Puig P
AU  - Martinez-Balibrea E
AU  - Sharma R
AU  - Garcia-Foncillas J
AU  - Kleibl Z
AU  - Morel A
AU  - Pignon JP
AU  - Midgley R
AU  - Kerr D
AU  - Tomlinson I
PY  - 2014
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco.2013.51.1857
UR  - https://doi.org/10.1200/jco.2013.51.1857
ER  - 

APA

D, R., C, P., D, C., E, D., A, J., E, J., H, W., S, L., P, J., C, S., G, N., A, G., M, M., D, S., E, G., H, M., UM, Z., M, S., M, B., M, S., L, T., B, L., V, B., N, R., S, A., H, E., SA, J., MC, E., G, M., M, W., B, G., H, G., M, G., T, L., P, L., E, M., R, S., J, G., Z, K., A, M., JP, P., R, M., D, K., & I, T. (2014). Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.2013.51.1857

Source records